Jul 05, 2022 8:00am EDT Former Itamar Medical CEO & President Gilad Glick Joins IceCure Medical as a Strategic Advisor for Global Go-To-Market Operations
Jul 04, 2022 2:30pm EDT Tracking News - More Details of Marketing Progress for IceSense3™ in Mainland China
Jun 15, 2022 8:00am EDT IceCure's ProSense® Featured at SIR 2022 Annual Meeting in Breast Cancer Cryoablation Categorical Course
Jun 13, 2022 8:00am EDT IceCure Medical, Shanghai Medtronic & Turing Medical Sign Distribution Agreement in Mainland China
Jun 09, 2022 8:00am EDT IceCure Medical's ProSense® Cryoablation System Submitted for Regulatory Approval in Brazil
May 18, 2022 7:00am EDT IceCure Medical Reports First Quarter 2022 Financial Results and Operational Highlights
May 11, 2022 2:09pm EDT IceCure Medical to Report Q1 2022 Results and Conduct Conference Call May 18, 2022
Apr 27, 2022 9:00am EDT IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoablation Symposium & Conducts Hands-On ProSense® Training Sessions at the European Conference on Interventional Oncology
Jan 31, 2022 8:00am EST IceCure Medical Announces Preliminary Unaudited 2021 Year-End Financial Results
